"Immunologic Treatment of Multiple Sclerosis"
Tania Reyna, MD
Clinical Assistant Member
Multiple Sclerosis Center of Excellence
Oklahoma Medical Research Foundation
1. Discuss current FDA approved medications for disease modification in multiple sclerosis.
2. Employ evidence-based strategies for switching therapies for patients who are experiencing breakthrough disease or not tolerating current treatment.